ATAI Life Sciences NVNASDAQ:ATAI
- LAST PRICE1.7800
- TODAY'S CHANGE (%)0.0500 (2.8902%)
- Bid / Lots1.7200/ 250
- Ask / Lots1.7800/ 48
- Open / Previous Close1.7500 / 1.7300
- Day Range
- 52 Week Range
- Volume658,932
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATAI |
|---|---|---|
| 09:32 ET | 20498 | 1.7502 |
| 09:33 ET | 4553 | 1.75 |
| 09:35 ET | 5038 | 1.735 |
| 09:37 ET | 4145 | 1.74 |
| 09:39 ET | 4069 | 1.73 |
| 09:42 ET | 2916 | 1.7291 |
| 09:44 ET | 2830 | 1.7328 |
| 09:46 ET | 2359 | 1.725 |
| 09:48 ET | 12544 | 1.74 |
| 09:50 ET | 7224 | 1.74 |
| 09:51 ET | 689 | 1.74 |
| 09:53 ET | 1460 | 1.75 |
| 09:55 ET | 1342 | 1.7488 |
| 09:57 ET | 1418 | 1.75 |
| 10:00 ET | 4723 | 1.745 |
| 10:02 ET | 610 | 1.7431 |
| 10:04 ET | 12208 | 1.74 |
| 10:06 ET | 9972 | 1.755 |
| 10:08 ET | 2125 | 1.7588 |
| 10:09 ET | 2302 | 1.755 |
| 10:11 ET | 1722 | 1.7549 |
| 10:13 ET | 24232 | 1.75 |
| 10:15 ET | 1745 | 1.75 |
| 10:18 ET | 4581 | 1.745 |
| 10:20 ET | 2620 | 1.745 |
| 10:22 ET | 9302 | 1.7499 |
| 10:24 ET | 4807 | 1.745 |
| 10:26 ET | 1442 | 1.745 |
| 10:27 ET | 1678 | 1.745 |
| 10:29 ET | 5140 | 1.732 |
| 10:31 ET | 4549 | 1.745 |
| 10:33 ET | 4050 | 1.739 |
| 10:36 ET | 3898 | 1.74 |
| 10:38 ET | 1397 | 1.74 |
| 10:40 ET | 2578 | 1.735 |
| 10:42 ET | 1783 | 1.735 |
| 10:44 ET | 4273 | 1.745 |
| 10:45 ET | 1879 | 1.75 |
| 10:47 ET | 709 | 1.745 |
| 10:49 ET | 1435 | 1.75 |
| 10:51 ET | 8507 | 1.75 |
| 10:54 ET | 2898 | 1.75 |
| 10:56 ET | 1324 | 1.74 |
| 10:58 ET | 991 | 1.75 |
| 11:00 ET | 9298 | 1.75 |
| 11:02 ET | 1600 | 1.75 |
| 11:03 ET | 13803 | 1.75 |
| 11:05 ET | 4736 | 1.75 |
| 11:07 ET | 3874 | 1.75 |
| 11:09 ET | 2744 | 1.7501 |
| 11:12 ET | 2276 | 1.7518 |
| 11:14 ET | 1853 | 1.755 |
| 11:16 ET | 260 | 1.7599 |
| 11:18 ET | 5115 | 1.745 |
| 11:20 ET | 3630 | 1.75 |
| 11:21 ET | 23138 | 1.76 |
| 11:23 ET | 1480 | 1.7524 |
| 11:25 ET | 13094 | 1.755 |
| 11:27 ET | 7141 | 1.76 |
| 11:30 ET | 3080 | 1.76 |
| 11:32 ET | 1906 | 1.75 |
| 11:34 ET | 400 | 1.76 |
| 11:36 ET | 1621 | 1.755 |
| 11:38 ET | 1427 | 1.75 |
| 11:39 ET | 5438 | 1.755 |
| 11:41 ET | 18274 | 1.765 |
| 11:43 ET | 7534 | 1.7641 |
| 11:45 ET | 25334 | 1.765 |
| 11:48 ET | 2479 | 1.7688 |
| 11:50 ET | 1753 | 1.765 |
| 11:52 ET | 2067 | 1.765 |
| 11:54 ET | 2896 | 1.77 |
| 11:56 ET | 2304 | 1.765 |
| 11:57 ET | 16494 | 1.77 |
| 11:59 ET | 2517 | 1.77 |
| 12:01 ET | 13004 | 1.775 |
| 12:03 ET | 6846 | 1.77 |
| 12:06 ET | 7287 | 1.77 |
| 12:08 ET | 2172 | 1.77 |
| 12:10 ET | 1405 | 1.77 |
| 12:12 ET | 4499 | 1.77 |
| 12:14 ET | 6799 | 1.77 |
| 12:15 ET | 787 | 1.775 |
| 12:17 ET | 14517 | 1.77 |
| 12:19 ET | 7222 | 1.775 |
| 12:21 ET | 1650 | 1.78 |
| 12:24 ET | 1938 | 1.7772 |
| 12:26 ET | 2210 | 1.78 |
| 12:28 ET | 23328 | 1.765 |
| 12:30 ET | 2308 | 1.77 |
| 12:32 ET | 1746 | 1.765 |
| 12:33 ET | 1779 | 1.77 |
| 12:35 ET | 1889 | 1.77 |
| 12:37 ET | 2228 | 1.7646 |
| 12:39 ET | 3408 | 1.77 |
| 12:42 ET | 2815 | 1.765 |
| 12:44 ET | 2000 | 1.765 |
| 12:46 ET | 5049 | 1.765 |
| 12:48 ET | 40692 | 1.7785 |
| 12:50 ET | 4635 | 1.7782 |
| 12:51 ET | 21204 | 1.78 |
| 12:53 ET | 1659 | 1.775 |
| 12:55 ET | 3736 | 1.7714 |
| 12:57 ET | 3694 | 1.77 |
| 01:00 ET | 30456 | 1.78 |
Nov 18, 2024
DJ ATAI Life Sciences Is Maintained at Buy by HC Wainwright & Co., from 12:57PM ET on Monday Nov 18, 2024 by Dow Jones
12:57PM ET on Monday Nov 18, 2024 by Dow JonesDJ ATAI Life Sciences Is Maintained at Buy by Canaccord Genuity, from 9:27AM ET on Monday Nov 18, 2024 by Dow Jones
9:27AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 13, 2024
Press Release: atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow Jonesatai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer, from 7:30AM ET on Monday Nov 11, 2024 by Dow Jones
7:30AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ATAI Life Sciences NV | 290.3M | -2.2x | --- |
aTyr Pharma Inc | 288.8M | -3.8x | --- |
Rezolute Inc | 289.1M | -4.0x | --- |
Aldeyra Therapeutics Inc | 294.2M | -6.5x | --- |
Nautilus Biotechnology Inc | 281.3M | -4.0x | --- |
Lexicon Pharmaceuticals Inc | 296.5M | -1.1x | --- |
Company Information
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Contact Information
- Headquarters
- Wallstrasse 16Berlin, Germany 10179
- Phone
- 892-153-9035
- Fax
- ---
Executives
- Chairman of the Supervisory Board
- Christian Angermayer
- Co-Chief Executive Officer
- Florian Brand
- Co-Chief Executive Officer
- Srinivas Rao
- Chief Financial Officer
- Anne Johnson
- Chief Business Officer
- Sahil Kirpekar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $290.3M |
|---|---|
Revenue (TTM) | $331.0K |
Shares Outstanding | 167.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $-0.80 |
Book Value | $1.46 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 877.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32,304.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
